Corning Incorporated will highlight its latest technologies that support the advancement of 3D cell culture, automation, and drug discovery at this year’s Society for Laboratory Automation and Screening (SLAS) keynote conference on 25 January through 27.
Now more than ever, tools used to scale-up, reproduce, and harmonize the consistency of 3D cell culture are helping to enable critical analysis needed to find a solution on the most important problems in the industry.
Corning shares the latest products in its 3D cell culture package, including Matrigel® matrix-3D plates, which can provide a more consistent, culture cell culture format ready to support organoid and spheroid culture models and reduce workflow steps. Also featured is Corning® The matrigel matrix for organoid culture, a vialed solution that has been proven to support the growth and differentiation of organoid culture and is also equipped to use stable “spherical 3D” structures commonly used in organoid culture.
New Corning Elplasia® blankets, which will be unveiled at the conference, will feature microcavity technology for high-density spheroid production, and Corning 3D’s clear print cleaning retrofit allows quick and easy images of 3D cultures . These new products are designed to address high-throughput screening and imaging for 3D cell culture, while at the same time maintaining reproducibility and consistency – common barriers in the widespread adoption of 3D workflows.
Corning Life Sciences experts – including John M. Tobin, vice president and general manager – will be available to discuss how these tools are being used to treat and develop treatments for a number of diseases and in other critical areas of study. Applications for these devices include drug screening, cancer and gas cell biology, 3D printing engineering, immunology, immuno-oncology, and personalized medicine.
In addition, Corning will be showcasing its automated and disease modeling solutions used in vaccine diagnostic, research and development workflows, as well as COVID-19 response-related efforts. These include lung organoids created using the Corning Matrigel matrix and air-liquid interface models manufactured by Transwell® and Falcon® permeable supports. The development of such complex 3D models can assist in the study of virus infection, helping to identify the best ways to treat and prevent disease. Other helpful tools, such as Corning robotic props and microplates assay, are used in diagnostic workflows, and upstream solutions in bio-product development support vaccine development.
Corning and its customers will also be offering a number of presentations at the SLAS virtual meeting including:
Tutorials
- Monday, January 25, 2021 12:30 – 1 p.m. EST
Tutorial: A “Gut-in-a-Dish” Model for Developing Personalized Remedies for Chronic Infectious Diseases
Presented by: Soumita Das, assistant professor, Department of Pathology, chief scientific director, HUMANOID, University of California San Diego - Wednesday, January 27, 2021
1:30 – 2f EST
Tutorial Session: High throughput applications with Organoids
Presented by: Hilary Sherman, senior scientist, Corning Life Sciences
To learn more about how Corning is helping to enable advances in 3D cell culture with innovative technologies and workflow solutions, check out the company’s # 11 digital booth and schedule a meaningful meeting with member of the Corning executive team.